DC WIHS Research Project

The DC WIHS site conducts research across a broad spectrum of topics related to HIV/AIDS. WIHS welcomes collaborations with outside investigators to utilize both the local and national data base and/or extensive specimen respository.The DC WIHS research team is available to assist with study design, data acquisition and analyses. Below is a partial list of recently completed, ongoing and proposed research by topic and investigator: 

 

HIV transmission networks among women in the District of Columbia

  • Seble Kassaye, M.D. 

Knowledge, attitudes, and beliefs about HIV pre-exposure prophylaxis (PrEP) and treatment as prevention (TasP)

  • Lakshmi Goparaju, Ph.D.
  • Lari Warren-Jeanpiere, Ph.D. 

The role of Vitamin C in HIV patients

  • ​Daniel Merenstein

Effect of anti-retroviral therapy on mechanisms of chemotherapy drug resistance in HIV positive patients

  • John Deeken, M.D. 

The mechanisms of sex hormone effects on HIV-1 infection dynamics

  • Athe Tsibris, M.D.

Hormonal regulation of anti-HIV activity in genital secretions

  • Mimi Ghosh, Ph.D.

Analysis of synergistic mechanisms contributing to the HCV-related liver disease among HIV-infected women

  • Jose Bordon, M.D., Ph.D. 

Molecular methods to improve cervical cancer screening 

  • Howard Strickler, M.D. 
  • Christine Colie, M.D.  

Natural history of CIN2

  • Christine Colie, M.D. 

HIV drug abusers, polymorphisms and brain plasticity

  • Italo Mocchetti, Ph.D.

Pharmacotherapy for hazardous drinking in HIV-infected women

  • Mary Young, M.D.

Microvascular endothelial functionality and aging in patients with HIV/AIDS

  • Dan Wang, M.D., Ph.D.
  • Christopher Wilcox, M.D., Ph.D.
  • Mary Young, M.D. 

Probing alterations of neuronal selectivity in middle aged HIV infected individuals

  • Xiong Jiang, Ph.D.

Disclosure of complementary and alternative medicine use to health care providers among HIV-infected women

  • Dan Merenstein, M.D.
  • Chenglong Liu, M.D., Ph.D.

Fungal biome in women with and at risk for HIV

  • Dan Merenstein, M.D.
  • Richard Calderone, Ph.D., M.S.

Study to evaluate risk factors for liver progression in HCV and HIV-infected women

  • Michael Plankey, Ph.D.

Data management and analysis support for the genomic Population study of HIV/AIDS

  • Chenglong Liu, M.D., Ph.D.

Microvascular disease in women with HIV

  • Christopher Wilcox, M.D., Ph.D.
  • Dan Wang, M.D., Ph.D.
  • Mary Young, M.D.

Effect of CAM usage on substance & alcohol abuse

  • Chenglong Liu, M.D., Ph.D.

The prevalence of hearing and balance loss in HIV/AIDS

  • Michael Plankey, Ph.D.

Using interpersonal psychotherapy for depression to enhance HAART adherence

  • Dan Merenstein, M.D.
  • Janice Krupnik, Ph.D.
  • Mary Young, M.D.

African-american and latina women aging with HIV: social support in HIV/AIDS management

  • Warren-JeanPierre, Ph.D.
  • Lakshmi Goparaju, Ph.D.

Disclosure of HIV status to family & friends: health outcomes in WIHS

  • Lakshmi Goparaju, Ph.D.
  • Maria Cecilia Zea, Ph.D.

Pilot study of fMRI in HAND

  • Chenglong Liu, M.D., Ph.D.
  • Xiong Jiang, Ph.D.

IL-4 in the modality of TH-1 response to mycobacterial TB

  • Jose Bordon, M.D., Ph.D.

Transporters of chemotherapy and HIV-associated medications

  • John Deeken, M.D.

Maternal disclosure of HIV serostatus to children

  • Priscilla Dass-Brailsford Ed.D.
  • Lakshmi Goparaju, Ph.D.

The role of the host response and liver damage in HIV/HCV co-infection

  • Jose Bordon, M.D., Ph.D.

Protein glycosylation in the accelerated progression of liver disease to hepatocellular carcinoma

  • Radoslav Goldman, Ph.D.